Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial | BMC Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 29 Aug 2020